Lisa advises executives of both large and small biotech companies on corporate strategy, commercial strategy, leadership and management, board management, and overall job performance. She was formerly the Chief Commercial Officer of Day One, and, prior to that role, was the CEO and founder of Rhia Ventures, a social venture investment organization focused on reproductive health. She has had an extensive career at Genentech/Roche, where she held P&L accountability for Genentech’s $400M+ cystic fibrosis business and was the head of the North American supply chain region, accountable for $20B+ of medicine across the United States and Canada.
Lisa has been a board member for Dice Therapeutics (acquired by Eli Lilly in 2023), a board observer for Cadence Health and a member of the board of Planned Parenthood Mar Monte, the largest Planned Parenthood affiliate in the country. She also writes a column on Medium about the biotech industry.